Validation of the COVID-19 Fear Scale modified for application during the perinatal period

• Main Authors: Alejandro Irvin Soto Briseño (Author), Rita A. Gomez-Diaz (Author), Ricardo Cesar Saldaña Espinoza (Author), Pilar Lavielle (Author), Adriana Leticia Valdez González (Author), Niels H. Wacher (Author)
• Format: Book
• Published: Taylor & Francis Group, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary

Purpose The COVID-19 Fear Scale (FCV-19S) allows screening in general population; however, there is no specific instrument in our population for screening in the perinatal period that considers fear related with COVID-19 and offspring well-being. We aimed to validate the FCV-19S modified for application during the perinatal period. Materials and methods Analytical, cross-sectional design. After signing consent, women 18-45 years were included. Internal consistency was calculated with Cronbach's alpha, external validity using the Hospital Anxiety and Depression Scale (HADS), factorial analysis and intraclass correlation coefficient for re-test. Results The sample included 178 women, mean age 31.04 ± 5.9. We obtained internal consistency with Cronbach's alpha = 0.873 (95%CI, 0.842-0.899). Spearman's Rho coefficient was 0.207 (p= .013). All the elements were statistically significant for the polychoric correlation (p<.001). Reliability test-retest with intraclass correlation was 0.873. Conclusions The version of FCV-19S modified with eight items is a valid measurement instrument for application during the perinatal period, showing adequate internal consistency and external validity with HADS as measure of concurrence to identify anxiety related with COVID-19 during the perinatal period.

Item Description

0167-482X
1743-8942
10.1080/0167482X.2022.2050210